Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

83.60 +1.99 (+2.44%)
Streaming Delayed Price Updated: 2:45 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,922,874
Open 82.62
Bid (Size) 83.59 (2)
Ask (Size) 83.60 (1)
Prev. Close 81.61
Today's Range 82.41 - 84.14
52wk Range 73.31 - 128.73
Shares Outstanding 2,531,374,696
Dividend Yield 3.88%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Abivax Hits The Stratosphere, Up 500%, On 'Potentially Disruptive' Results
The results represent a best-case scenario for the company in treating inflammatory bowel disease, according to one analyst. 
Via Investor's Business Daily
Why Replimune's Surprise Rejection Rattled Wall Street, And Cratered Its Stock
The company had lined up a priority review in the hopes of winning an accelerated approval for its melanoma treatment. 
Via Investor's Business Daily

Performance

YTD
-15.7%
-15.7%
1 Month
+4.3%
+4.3%
3 Month
+5.9%
+5.9%
6 Month
-13.1%
-13.1%
1 Year
-33.5%
-33.5%

More News

Read More
Merck Announces Fourth-Quarter 2025 Dividend
From Merck & Co., Inc.
Via Business Wire
MERCK & CO. INC. (NYSE:MRK) – A Quality Stock with Strong Fundamentals
Via Chartmill
Merck Commits To Veeva’s Vault CRM, Draws Wall Street Cheer: Retail’s Not Enthusiastic
Via Stocktwits
Merck’s Blockbuster Drug Keytruda Gets Canadian Regulator’s Approval For Treating Cervical Cancer: Retail Investors Appear Divided
Via Stocktwits
Merck & Co Unusual Options Activity For July 15
Via Benzinga
Adagene Receives FDA Guidance On Future Clinical Development Of Experimental Cancer Drug: Retail Turns Optimistic
Via Stocktwits
Does This Move Make Merck Stock a Buy?
Via The Motley Fool
Topics Intellectual Property
Should You Forget Pfizer and Buy This Magnificent Dividend Stock Instead?
Via The Motley Fool
Topics Economy Intellectual Property
Want Decades of Passive Income? Buy This ETF and Hold It Forever
Via The Motley Fool
Topics ETFs Regulatory Compliance Stocks
MERCK ALERT: Bragar Eagel & Squire, P.C. is Investigating Merck & Co., Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Got $200? 2 Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
Merck Just Announced a $10 Billion Deal That Will Help Diversify Its Business
Via The Motley Fool
Topics Intellectual Property
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
1 Dow Jones Stock to Target This Week and 2 to Avoid
Via StockStory
Topics Stocks
GSK Seeks FDA Nod To Broaden RSV Vaccine For Younger At-Risk Adults
Via Benzinga
This House of Representative Just Bought Up To $30K In 3M Stock
Via Benzinga
Is Bristol-Myers Squibb Still An Undervalued Biopharma Play?
Via Benzinga
Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill
From Merck & Co., Inc.
Via Business Wire
AstraZeneca's Drug Shows Promise For Resistant Hypertension In Phase 3 Trial
Via Benzinga
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
Via Benzinga
Topics Government World Trade
MERCK & CO. INC. (NYSE:MRK) – A Strong Dividend Stock with Solid Fundamentals
Via Chartmill
2 Top Stocks Down 16% and 17% This Year to Buy and Hold
Via The Motley Fool
Topics Intellectual Property
FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health
From Merck & Co., Inc.
Via Business Wire

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 83.60
When was Merck & Co last traded?
The last trade of Merck & Co was at 07/23/25 02:45 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 211.62B
How many shares of Merck & Co are outstanding?
Merck & Co has 212B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.